Clywedog Therapeutics, Inc. (CLYD)

Clywedog Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025
Period Ending	Dec 31, 2025	Dec 31, 2025
Operating Income Operating Income Growth	-14.83	-14.83
Net Income Net Income Growth	-17.01	-17.01
Earnings Per Share EPS Growth	-11.25	-11.25
EPS Growth	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025
Period Ending	Dec 31, 2025	Dec 31, 2025
Cash & Investments Cash & Investments Growth	0.22	0.22
Total Debt Total Debt Growth	1.48	1.48
Net Cash (Debt) Net Cash Growth	-1.26	-1.26
Net Cash Growth	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.83	-0.83

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Sep 26, 2026

Data Sources Report a data error